Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1109705

registered interest
date	04/04/2019
answering body	Department for Digital, Culture, Media and Sport
answering dept id	10
answering dept short name	Digital, Culture, Media and Sport
answering dept sort name	Digital, Culture, Media and Sport
hansard heading	Voluntary Work: Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Digital, Culture, Media and Sport, pursuant to the Answer of 2 April 2019 to Question 238396, whether all participants in the National Citizens Service are charged the maximum £50 sign-up fee.
tabling member constituency	Lancaster and Fleetwood
tabling member printed	Cat Smith
uin	241058
answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>Not all participants are charged the maximum £50 sign up fee. Partial and full bursaries are available to ensure the programme is accessible to every young person who wants a place.</p> answering member constituency Eastleigh answering member printed Mims Davies question first answered 09/04/2019 15:29:08 answering member 4513 label Biography information for Mims Davies
tabling member	4436 label Biography information for Cat Smith

1107796

registered interest
date	29/03/2019
answering body	Department for Digital, Culture, Media and Sport
answering dept id	10
answering dept short name	Digital, Culture, Media and Sport
answering dept sort name	Digital, Culture, Media and Sport
hansard heading	Youth Organisations: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Digital, Culture, Media and Sport, pursuant to the Answer of 11 October 2018 to Question 176383, how much funding has been released from dormant bank accounts to support young people.
tabling member constituency	Lancaster and Fleetwood
tabling member printed	Cat Smith
uin	238656
answer	answer is ministerial correction date of answer 03/04/2019 answer text <p>As part of the Civil Society Strategy, the Government committed to working with the National Lottery Community Fund to allocate £90 million from dormant bank accounts to a new, independent organisation to support young people furthest away from the labour market. Last week, the Youth Futures Foundation (YFF) launched and announced its Founding Chair, Joe Montgomery.</p><p> </p><p>Over the coming months, YFF will set out its strategy for using this funding to support the most disadvantaged young people into employment. Funding is supporting small, grassroot youth organisations working with young people Not in Employment, Education or Training (NEET) or at risk of becoming NEET, to build their organisational capacity and strengthen local partnerships.</p> answering member constituency Eastleigh answering member printed Mims Davies question first answered 03/04/2019 16:09:21 answering member 4513 label Biography information for Mims Davies
tabling member	4436 label Biography information for Cat Smith

1107804

registered interest
date	29/03/2019
answering body	Department for Digital, Culture, Media and Sport
answering dept id	10
answering dept short name	Digital, Culture, Media and Sport
answering dept sort name	Digital, Culture, Media and Sport
hansard heading	Voluntary Work: Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Digital, Culture, Media and Sport, pursuant to the Answer of 25 Feb 2019 to Question 223803, what the final (a) participation and (b) completion figures for the National Citizenship Service programme were for 2018; and if will publish the (i) original and (ii) revised Government targets for each year since 2011.
tabling member constituency	Lancaster and Fleetwood
tabling member printed	Cat Smith
uin	238657
answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>The final participation and completion figures for the National Citizen Service programme in 2018 are undergoing compliance checks and will be published on gov.uk once they are finalised.</p><p> </p><p>Government targets have been agreed annually between the sponsoring Government Department and the NCS Trust in line with NCS Trust projections of demand. The table attached shows annual targets and participation ceilings.</p><p> </p><p>A maximum participation ceiling was allocated to NCS in the 2015 Spending Review to ensure that no young people were turned away from the programme. This was not a participation target. The ceiling was revised downwards in the 2017 revised Spending Review settlement.</p> answering member constituency Eastleigh answering member printed Mims Davies question first answered 04/04/2019 16:03:45 answering member 4513 label Biography information for Mims Davies attachment 1 file name Annual target data.pdf title Annual Target Data
tabling member	4436 label Biography information for Cat Smith

1105882

registered interest
date	28/03/2019
answering body	Department for Digital, Culture, Media and Sport
answering dept id	10
answering dept short name	Digital, Culture, Media and Sport
answering dept sort name	Digital, Culture, Media and Sport
hansard heading	Voluntary Work: Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Digital, Culture, Media and Sport, pursuant to the Answer of 26 March 2019 to Question 235376 on Voluntary Work: Young People, what the sources are of past non-public income generated to fund NCS and the forecasted £3 million of income for the upcoming financial year.
tabling member constituency	Lancaster and Fleetwood
tabling member printed	Cat Smith
uin	238396
answer	answer is ministerial correction date of answer 02/04/2019 answer text <p>Historically, the main source of non-public income generated for NCS has been the £50 sign-up fee. A small amount of income has occasionally come from other sources, such as corporate sponsorships.</p><p> </p><p>The forecasted circa £3 million income for the upcoming financial year will be generated from sign-up fees.</p> answering member constituency Eastleigh answering member printed Mims Davies question first answered 02/04/2019 10:30:39 answering member 4513 label Biography information for Mims Davies
tabling member	4436 label Biography information for Cat Smith

1092654

registered interest
date	21/03/2019
answering body	Department for Digital, Culture, Media and Sport
answering dept id	10
answering dept short name	Digital, Culture, Media and Sport
answering dept sort name	Digital, Culture, Media and Sport
hansard heading	Voluntary Work: Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Digital, Culture, Media and Sport, what the source of funding is for the £10 million brand refresh for the National Citizen Service; and whether he can confirm that no government funding will be spent on this contract.
tabling member constituency	Lancaster and Fleetwood
tabling member printed	Cat Smith
uin	235376
answer	answer is ministerial correction date of answer 26/03/2019 answer text <p>To date, over 500,000 young people have taken part in the NCS programme. The most recently published evaluation has found that 82% of young people felt more positive about people from different backgrounds, and participants are more likely to use their time to help others after NCS<sup><sup>[1]</sup></sup>. Marketing is a key recruitment driver for NCS, ensuring that more young people across the country benefit from the programme.</p><p> </p><p>The brand refresh is one part of the overall marketing and creative services tender which includes communications planning, creative strategy, brand platform, experience, advertising campaign development, and content production. The £10m figure was stated in a NCS Trust procurement document as an upper limit over 4 years. The actual cost of the contract is likely to be around £1m per year, for 4 years of the contract.</p><p> </p><p>The NCS Trust is forecast to self-generate c. £3m income in the upcoming financial year. The brand refresh element of the marketing and creative services contract in question will be paid from those funds and we can confirm that no government funding will be spent on this element of the contract. The remainder of the contract will be funded by Government funding.</p><p> </p><p><sup><sup>[1]</sup></sup> This figure is based on the 2016 programme evaluation, which can be found <a href="https://www.gov.uk/government/publications/national-citizen-service-evaluation-report-2016" target="_blank">here</a>. The 2017 evaluation report is currently being finalised.</p><p> </p> answering member constituency Eastleigh answering member printed Mims Davies question first answered 26/03/2019 13:42:17 answering member 4513 label Biography information for Mims Davies
tabling member	4436 label Biography information for Cat Smith

1088401

registered interest
date	13/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy: Sodium Valproate
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of the valproate pregnancy prevention programme in reducing the number of children born with birth defects and persistent developmental disorders.
tabling member constituency	Lancaster and Fleetwood
tabling member printed	Cat Smith
uin	232043
answer	answer is ministerial correction date of answer 21/03/2019 answer text <p>In April 2018, strengthened regulatory measures for valproate were introduced following a European-wide review of the latest evidence on harms from valproate exposure during pregnancy, including congenital anomalies and neurodevelopmental disorders including autism in children. These measures include the valproate Pregnancy Prevention Programme, the goal of which is to rapidly reduce and eventually eliminate pregnancies exposed to valproate.</p><p> </p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) is monitoring the impact of, and adherence to, the strengthened regulatory recommendations for valproate including the Pregnancy Prevention Programme, using research studies and routinely collected healthcare data. These include data from the Clinical Practice Research Datalink, national databases in England (NHS Business Services Authority and NHS Digital), Scotland (Information Services Division), and Northern Ireland (Health and Social Care Northern Ireland) linking community drug dispensing and maternity services data where these are available. The MHRA is also accessing data on valproate from clinical audits run by healthcare professional organisations, and information on patients’ experience of introduction of the strengthened regulatory measures via surveys conducted by charitable organisations and patient groups.</p><p> </p><p>Monitoring of prescribing of valproate has shown a slow, continued decline in women of childbearing age. Data show variability in levels of prescribing of valproate to women of childbearing age across different clinical commissioning groups in England. The current monitoring methods used by the MHRA do not enable comprehensive monitoring of compliance at the prescriber or patient level. It is therefore not possible to estimate the number of healthcare professionals who are not complying with all aspects of the Pregnancy Prevention Programme. Surveys of patient experiences have shown some evidence of non-compliance amongst healthcare professionals with the valproate Pregnancy Prevention Programme. Actions are being taken by the relevant professional regulators to follow up and address this.</p><p> </p><p>The recent European review of valproate in pregnancy considered a possible association between birth defects and persistent developmental disorders associated with paternal valproate treatment at the time of conception. The review concluded that there was insufficient evidence at present to establish such a link. A retrospective observational study is to be undertaken to further investigate this issue for which a study protocol is currently being agreed by the European Medicines Agency.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 232044 232045 question first answered 21/03/2019 12:14:16 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4436 label Biography information for Cat Smith

1088402

registered interest
date	13/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy: Sodium Valproate
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made on the number of healthcare professionals that are not complying with the requirements of the valproate pregnancy prevention programme.
tabling member constituency	Lancaster and Fleetwood
tabling member printed	Cat Smith
uin	232044
answer	answer is ministerial correction date of answer 21/03/2019 answer text <p>In April 2018, strengthened regulatory measures for valproate were introduced following a European-wide review of the latest evidence on harms from valproate exposure during pregnancy, including congenital anomalies and neurodevelopmental disorders including autism in children. These measures include the valproate Pregnancy Prevention Programme, the goal of which is to rapidly reduce and eventually eliminate pregnancies exposed to valproate.</p><p> </p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) is monitoring the impact of, and adherence to, the strengthened regulatory recommendations for valproate including the Pregnancy Prevention Programme, using research studies and routinely collected healthcare data. These include data from the Clinical Practice Research Datalink, national databases in England (NHS Business Services Authority and NHS Digital), Scotland (Information Services Division), and Northern Ireland (Health and Social Care Northern Ireland) linking community drug dispensing and maternity services data where these are available. The MHRA is also accessing data on valproate from clinical audits run by healthcare professional organisations, and information on patients’ experience of introduction of the strengthened regulatory measures via surveys conducted by charitable organisations and patient groups.</p><p> </p><p>Monitoring of prescribing of valproate has shown a slow, continued decline in women of childbearing age. Data show variability in levels of prescribing of valproate to women of childbearing age across different clinical commissioning groups in England. The current monitoring methods used by the MHRA do not enable comprehensive monitoring of compliance at the prescriber or patient level. It is therefore not possible to estimate the number of healthcare professionals who are not complying with all aspects of the Pregnancy Prevention Programme. Surveys of patient experiences have shown some evidence of non-compliance amongst healthcare professionals with the valproate Pregnancy Prevention Programme. Actions are being taken by the relevant professional regulators to follow up and address this.</p><p> </p><p>The recent European review of valproate in pregnancy considered a possible association between birth defects and persistent developmental disorders associated with paternal valproate treatment at the time of conception. The review concluded that there was insufficient evidence at present to establish such a link. A retrospective observational study is to be undertaken to further investigate this issue for which a study protocol is currently being agreed by the European Medicines Agency.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 232043 232045 question first answered 21/03/2019 12:14:16 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4436 label Biography information for Cat Smith

1088403

registered interest
date	13/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy: Sodium Valproate
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of link between birth defects and persistent developmental disorders and fathers taking valproate at the time of conception.
tabling member constituency	Lancaster and Fleetwood
tabling member printed	Cat Smith
uin	232045
answer	answer is ministerial correction date of answer 21/03/2019 answer text <p>In April 2018, strengthened regulatory measures for valproate were introduced following a European-wide review of the latest evidence on harms from valproate exposure during pregnancy, including congenital anomalies and neurodevelopmental disorders including autism in children. These measures include the valproate Pregnancy Prevention Programme, the goal of which is to rapidly reduce and eventually eliminate pregnancies exposed to valproate.</p><p> </p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) is monitoring the impact of, and adherence to, the strengthened regulatory recommendations for valproate including the Pregnancy Prevention Programme, using research studies and routinely collected healthcare data. These include data from the Clinical Practice Research Datalink, national databases in England (NHS Business Services Authority and NHS Digital), Scotland (Information Services Division), and Northern Ireland (Health and Social Care Northern Ireland) linking community drug dispensing and maternity services data where these are available. The MHRA is also accessing data on valproate from clinical audits run by healthcare professional organisations, and information on patients’ experience of introduction of the strengthened regulatory measures via surveys conducted by charitable organisations and patient groups.</p><p> </p><p>Monitoring of prescribing of valproate has shown a slow, continued decline in women of childbearing age. Data show variability in levels of prescribing of valproate to women of childbearing age across different clinical commissioning groups in England. The current monitoring methods used by the MHRA do not enable comprehensive monitoring of compliance at the prescriber or patient level. It is therefore not possible to estimate the number of healthcare professionals who are not complying with all aspects of the Pregnancy Prevention Programme. Surveys of patient experiences have shown some evidence of non-compliance amongst healthcare professionals with the valproate Pregnancy Prevention Programme. Actions are being taken by the relevant professional regulators to follow up and address this.</p><p> </p><p>The recent European review of valproate in pregnancy considered a possible association between birth defects and persistent developmental disorders associated with paternal valproate treatment at the time of conception. The review concluded that there was insufficient evidence at present to establish such a link. A retrospective observational study is to be undertaken to further investigate this issue for which a study protocol is currently being agreed by the European Medicines Agency.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 232043 232044 question first answered 21/03/2019 12:14:16 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4436 label Biography information for Cat Smith

1079587

registered interest
date	01/03/2019
answering body	Cabinet Office
answering dept id	53
answering dept short name	Cabinet Office
answering dept sort name	Cabinet Office
hansard heading	Electoral Register
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Minister for the Cabinet Office, pursuant to the Answer of 28 February 2019 to Question, if he will make an assessment of the potential merits of requiring the compatibility of registration officers’ systems for managing registration data between local authority areas.
tabling member constituency	Lancaster and Fleetwood
tabling member printed	Cat Smith
uin	227388
answer	answer is ministerial correction date of answer 07/03/2019 answer text <p>The Government has no immediate plans to assess the potential merits of requiring the compatibility of registration officers’ systems for managing registration data between local authority areas. All registration officers’ systems have compatibility with the Individual Electoral Registration Digital Service (IERDS), which allows Electoral Registration Officers to notify other officers of moved electors, as well as other functionalities. Cabinet Office officials are, however, working on a continual basis to ensure all necessary improvements are made to the IERDS to ensure it serves the needs of local Electoral Registration Officers.</p> answering member constituency Norwich North answering member printed Chloe Smith question first answered 07/03/2019 16:56:31 answering member 1609 label Biography information for Chloe Smith
tabling member	4436 label Biography information for Cat Smith

1078467

registered interest
date	27/02/2019
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	High Speed 2 Line: Lancaster
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Transport, pursuant to the Answer of 22 February 2019 to Question 221779, High Speed Two: Lancaster, if he will meet (a) the hon. Member for Lancaster and Fleetwood and (b) Lancaster business leaders to discuss High Speed Two.
tabling member constituency	Lancaster and Fleetwood
tabling member printed	Cat Smith
uin	226699
answer	answer is ministerial correction date of answer 04/03/2019 answer text <p>I understand the importance of HS2 to the north west and specifically to Lancaster. As I stated in my recent letter to you, I have asked my officials to set up a meeting to ensure that your concerns are heard.</p> answering member constituency Wealden answering member printed Ms Nusrat Ghani question first answered 04/03/2019 16:02:19 answering member 4460 label Biography information for Ms Nusrat Ghani
tabling member	4436 label Biography information for Cat Smith